Reese–Ellsworth Group | Outcome of eyes (n = 44) | |||
Enucleated before primary chemotherapy* | Enucleated after primary chemotherapy but before EBRT* | Enucleated after EBRT | Salvaged (percentage of group) | |
Normal | 0 | 0 | 0 | 4 (100%) |
I a | 0 | 0 | 0 | 4 (100%) |
I b | 0 | 0 | 0 | 6 (100%) |
II a | 0 | 0 | 0 | 3 (100%) |
III a | 0 | 1 | 1 | 1 (33.3%) |
III b | 0 | 2 | 0 | 2 (50.0%) |
IV a | 0 | 1 | 2 | 5 (62.5%) |
V a | 3 | 0 | 2 | 2 (28.6%) |
V b | 1 | 0 | 1 | 3 (60.0%) |
*Eyes that were enucleated before external beam radiotherapy (EBRT) were not included in the analysis of the study.